Well, nothing can spoil the news from earlier on Interim results.
Wait & see where we are at with the CR business, maybe it will be a combined thing with milestone payment, cornerstone investor & possibly even old mate Peter Meurs, he has stumped up a few times in the past, which I’m sure we all appreciate to get us to this point.
Anyone got a current tally on where we are at with options? I can’t see that folk won’t convert the remaining 12.6c oppies now before end of March.
Have a great day folks
Ann: Dimerix Successfully Passes Efficacy Interim Analysis, page-39
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $214.5M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.0¢ | 38.0¢ | $367.7K | 949.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 35576 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 727 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |